A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal Osteoporosis.

Paul T, Garg B, Kapoor N, Patil V, Kachnerkar N, Shembalkar J, Purohit S, Maheshwari S, Maheshwari S, Yadav A, Cherian JJ, Agrawal A, Basu K, Tripathy SK, Pongde AB, Goni V, Markade P, Makane A, Tiwaskar M, Cherian KE, Rane Y, Shahavi V, Poojary V, Somani R, Gondane A, Aiwale A, Pawar D, Pawar R, Sharma A

Open source

DOI: 10.59556/japi.73.0772
Published: 2025 Jan
Container: The Journal of the Association of Physicians of India
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.59556/japi.73.0772,
  title = {A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal Osteoporosis.},
  author = {Paul T and Garg B and Kapoor N and Patil V and Kachnerkar N and Shembalkar J and Purohit S and Maheshwari S and Maheshwari S and Yadav A and Cherian JJ and Agrawal A and Basu K and Tripathy SK and Pongde AB and Goni V and Markade P and Makane A and Tiwaskar M and Cherian KE and Rane Y and Shahavi V and Poojary V and Somani R and Gondane A and Aiwale A and Pawar D and Pawar R and Sharma A},
  year = {2025},
  journal = {The Journal of the Association of Physicians of India},
  doi = {10.59556/japi.73.0772},
  url = {https://doi.org/10.59556/japi.73.0772}
}

RIS

TY  - JOUR
TI  - A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal Osteoporosis.
AU  - Paul T
AU  - Garg B
AU  - Kapoor N
AU  - Patil V
AU  - Kachnerkar N
AU  - Shembalkar J
AU  - Purohit S
AU  - Maheshwari S
AU  - Maheshwari S
AU  - Yadav A
AU  - Cherian JJ
AU  - Agrawal A
AU  - Basu K
AU  - Tripathy SK
AU  - Pongde AB
AU  - Goni V
AU  - Markade P
AU  - Makane A
AU  - Tiwaskar M
AU  - Cherian KE
AU  - Rane Y
AU  - Shahavi V
AU  - Poojary V
AU  - Somani R
AU  - Gondane A
AU  - Aiwale A
AU  - Pawar D
AU  - Pawar R
AU  - Sharma A
PY  - 2025
JO  - The Journal of the Association of Physicians of India
DO  - 10.59556/japi.73.0772
UR  - https://doi.org/10.59556/japi.73.0772
ER  -

APA

T, P., B, G., N, K., V, P., N, K., J, S., S, P., S, M., S, M., A, Y., JJ, C., A, A., K, B., SK, T., AB, P., V, G., P, M., A, M., M, T., KE, C., Y, R., V, S., V, P., R, S., A, G., A, A., D, P., R, P., & A, S. (2025). A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal Osteoporosis.. The Journal of the Association of Physicians of India. https://doi.org/10.59556/japi.73.0772

Source records

pubmed · retrieved 2026-09-26T06:32:51.507Z